Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to ...

Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...

A new study is shedding light on the safety profile of psilocybin, the active ingredient in so-called “magic mushrooms.” Published on Tuesday in the Journal of Psychopharmacology, the study looks at ...

A new analysis of clinical trial data indicates that psilocybin, when administered alongside psychotherapy, may provide rapid ...

Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...

In a recently published preprint study, entitled “Psilocybin desynchronizes brain networks,” researchers analyze the comparison between psilocybin and the default mode network (DMN) of the brain.

A new study published in the Journal of Psychopharmacology found that serotonergic antidepressants like SSRIs and SNRIs can decrease psilocybin’s effects, Psychedelic Spotlight reports. Serotonergic ...

One of the first studies to examine a psychedelic's effects on the mental health of healthcare workers has received a green light from the FDA and is set to start, according to sources and reports.

On Tuesday, November 12th, students at the University of Wisconsin received an email from the Raison Lab asking if they were interested in a lab studying the effect of psilocybin. The study offered up ...

The substantial antidepressant effects of psilocybin-assisted therapy may be durable up to at least 1 year in some patients with major depressive disorder (MDD), new research indicates. Two doses of ...